NCT07166289View on ClinicalTrials.gov

Ultrasound Neuromodulation of Circuits and Negative Valence Systems in Treatment-Resistant Depression

NANot yet recruitingINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

April 30, 2030

Study Completion Date

July 31, 2030

Conditions
Treatment-Resistant Depression
Interventions
OTHER

Low-intensity focused ultrasound

80-second stimulus with an estimated tissue ISSPA=2.26 W/cm2, with (sham) or without (verum) interposition of Sorbothane film

Trial Locations (1)

74136

Laureate Institute for Brain Research, Tulsa

Sponsors
All Listed Sponsors
lead

Laureate Institute for Brain Research, Inc.

OTHER

NCT07166289 - Ultrasound Neuromodulation of Circuits and Negative Valence Systems in Treatment-Resistant Depression | Biotech Hunter | Biotech Hunter